DMD candidate DS-5141 receives Sakigake designation in Japan

Japan granted Sakigake designation to DS-5141 (DS-5141b) from Daiichi Sankyo Co. Ltd. (Tokyo:4568) to treat Duchenne muscular dystrophy (DMD). DS-5141 is an ethylene-bridged nucleic acid (ENA) oligon...